Anti ARL4C pAb (ATL-HPA028927 w/enhanced validation)

Atlas Antibodies

Catalog No.: ATL-HPA028927-25

Protein Description: ADP-ribosylation factor-like 4C
Gene Name: ARL4C
Alternative Gene Name: ARL7, LAK
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000049866: 100%, ENSRNOG00000004282: 64%
Entrez Gene ID: 10123
Uniprot ID: P56559
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, ICC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: GIIYVVDSVDVDRLEEAKTELHKVTKFAENQGTPLLVIANKQDLPKSLPVAEIEKQLALHELIPATTYHVQPACAIIGEGLTEGMDKLYEMILKRRKSLKQKKKR
• Gene Sequence: GIIYVVDSVDVDRLEEAKTELHKVTKFAENQGTPLLVIANKQDLPKSLPVAEIEKQLALHELIPATTYHVQPACAIIGEGLTEGMDKLYEMILKRRKSLKQKKKR
• Gene ID - Mouse: ENSMUSG00000049866
• Gene ID - Rat: ENSRNOG00000004282
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti ARL4C pAb (ATL-HPA028927 w/enhanced validation) – 3 Found

Guo, Xiangqian; Jo, Vickie Y; Mills, Anne M; Zhu, Shirley X; Lee, Cheng-Han; Espinosa, Inigo; Nucci, Marisa R; Varma, Sushama; Forgó, Erna; Hastie, Trevor; Anderson, Sharon; Ganjoo, Kristen; Beck, Andrew H; West, Robert B; Fletcher, Christopher D; van de Rijn, Matt. Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2015;21(15):3501-11. 

Harada, Akikazu; Matsumoto, Shinji; Yasumizu, Yoshiaki; Shojima, Kensaku; Akama, Toshiyuki; Eguchi, Hidetoshi; Kikuchi, Akira. Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. Elife. 2021;10( 34590580) 

An, Yang; Wang, Shuzhen; Li, Songlin; Zhang, Lulu; Wang, Dayong; Wang, Haojie; Zhu, Shibai; Zhu, Wan; Li, Yongqiang; Chen, Wenwu; Ji, Shaoping; Guo, Xiangqian. Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment. Bmc Cancer. 2017;17(1):639.